MedTrace Logo

Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis

NCT00707785 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 424

Last updated 2013-09-25

No results posted yet for this study

Summary

The purpose of the study is to determine whether vitamin A can improve survival and facilitate recovery from sepsis and necrotizing enterocolitis in hospitalized neonates.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin A

50,000 IU of Vitamin A 50,000 IU of vegetable oil

Sponsors & Collaborators

  • Bill and Melinda Gates Foundation

    collaborator OTHER

  • United States Agency for International Development (USAID)

    collaborator FED

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Christian L Coles, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2011-04-30
Completion
2012-06-30

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00707785 on ClinicalTrials.gov